The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,080.00
Bid: 3,090.00
Ask: 3,092.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.065%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3,080.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

14 Dec 2017 07:00

RNS Number : 2751Z
Bunzl PLC
14 December 2017
 

 

 

14 December 2017

 

BUNZL PRE CLOSE STATEMENT AND ACQUISITION IN THE UK

 

Bunzl plc, the international distribution and outsourcing Group, is updating the market today relating to the year ending 31 December 2017 prior to entering its close period.

 

Overall trading is consistent with expectations at the time of the third quarter trading statement in October. Group revenue for the year is expected to have increased by approximately 15% at actual exchange rates. At constant exchange rates revenue is expected to have risen by between 9% and 10% due to similar levels of growth from both organic revenue and the impact of acquisitions. The growth in organic revenue is principally due to the previously announced additional business won, albeit at lower margins, in North America towards the end of 2016.

 

The ability to consolidate the Company's fragmented markets through acquisitions is an important part of the ongoing strategy of Bunzl and the Company also today announces the purchase of Lightning Packaging in the UK. The business is principally engaged in the distribution of industrial packaging products to a variety of end user customers operating in a number of market sectors throughout the UK. Revenue in the year ended March 2017 was £14 million.

 

This year has seen a record level of acquisition spend for Bunzl of approximately £600 million which significantly exceeds the previous high of £327 million achieved in 2015. The pipeline for acquisitions remains active.

 

 

 

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive

Brian May, Finance Director

Tel: +44 (0)20 7725 5000

Tulchan

David Allchurch

Martin Robinson

Tel: +44 (0)20 7353 4200

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBUBDDUXBBGRX
Date   Source Headline
29th Mar 20184:15 pmRNSDirector/PDMR Shareholding
22nd Mar 20184:00 pmRNSDirector/PDMR Shareholding
21st Mar 201810:44 amRNSHolding(s) in Company
15th Mar 20184:27 pmRNSAnnual Financial Report
12th Mar 20184:48 pmRNSDirector/PDMR Shareholding
5th Mar 201811:54 amRNSHolding(s) in Company
2nd Mar 20184:16 pmRNSDirector/PDMR Shareholding
2nd Mar 20183:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20183:23 pmRNSDirector/PDMR Shareholding
1st Mar 201811:06 amRNSTotal Voting Rights
26th Feb 201810:22 amRNSDividend Declaration
26th Feb 20187:00 amRNSFinal Results
23rd Feb 20188:00 amRNSAdditional Listing
22nd Feb 20183:30 pmRNSDirector Declaration
13th Feb 20189:06 amRNSHolding(s) in Company
2nd Feb 20184:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20188:00 amRNSAdditional Listing
1st Feb 20184:12 pmRNSTotal Voting Rights
22nd Jan 20188:00 amRNSAdditional Listing
11th Jan 20187:00 amRNSImpact of US Tax Legislation
11th Jan 20187:00 amRNSAcquisition
9th Jan 20184:47 pmRNSDirector/PDMR Shareholding
3rd Jan 20181:38 pmRNSDirector/PDMR Shareholding
2nd Jan 20184:08 pmRNSTotal Voting Rights
21st Dec 20178:00 amRNSAdditional Listing
18th Dec 20174:00 pmRNSHolding(s) in Company
14th Dec 20177:00 amRNSTrading Statement
13th Dec 20179:11 amRNSHolding(s) in Company
7th Dec 201711:36 amRNSIssue of Debt
1st Dec 20174:12 pmRNSTotal Voting Rights
1st Dec 20177:00 amRNSIssue of Debt
30th Nov 20178:00 amRNSAdditional Listing
23rd Nov 20177:00 amRNSAcquisition
17th Nov 20171:18 pmRNSDirector/PDMR Shareholding
15th Nov 201711:49 amRNSHolding(s) in Company
13th Nov 20173:01 pmRNSDividend Reinvestment Plan Terms and Conditions
1st Nov 20173:05 pmRNSBlock listing Interim Review
1st Nov 20172:57 pmRNSTotal Voting Rights
24th Oct 20177:00 amRNSTrading Statement
12th Oct 201710:45 amRNSDirector/PDMR Shareholding
9th Oct 20175:30 pmRNSDirector/PDMR Shareholding
9th Oct 20175:25 pmRNSDirector/PDMR Shareholding
9th Oct 20175:21 pmRNSDirector/PDMR Shareholding
6th Oct 20174:00 pmRNSDirector/PDMR Shareholding
6th Oct 201712:20 pmRNSDirector/PDMR Shareholding
5th Oct 20173:55 pmRNSHolding(s) in Company
2nd Oct 201711:30 amRNSTotal Voting Rights
29th Sep 20174:15 pmRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSCapital Markets Event
22nd Sep 20173:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.